Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Neurobiology of Disease

• Publication date

  2006-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.nbd.2005.09.004PMID 16257224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• On the utility of pooling biological samples in microarray experiments.

  2005cited by this paper
• Calcium Dysregulation, IP3 Signaling, and Alzheimer’s Disease

  2005cited by this paper
• A chapter in the unity of variety--calcium is the sole author?

  2004cited by this paper
• Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain.

  2004cited by this paper
• Amyloid precursor protein mRNA levels in Alzheimer's disease brain.

  2004cited by this paper
• Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses

  2004cited by this paper
• Preliminary studies on Alzheimer's disease using cDNA microarrays.

  2003cited by this paper
• GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.

  2003cited by this paper
• Inositol 1,3,4,5-tetrakisphosphate is essential for T lymphocyte development

  2003cited by this paper
• Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease.

  2003cited by this paper
• Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease.

  2003cited by this paper
• Altered expression of regulators of G-protein signaling (RGS) mRNAs in the striatum of rats undergoing dopamine depletion.

  2003cited by this paper
• Statistical issues in cDNA microarray data analysis.

  2003cited by this paper
• Decrease of serotonin receptor 2C in schizophrenia brains identified by high-resolution mRNA expression analysis.

  2003cited by this paper
• GSK-3α regulates production of Alzheimer's disease amyloid-β peptides

  2003cited by this paper
• Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients.

  2002cited by this paper
• Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.

  2002cited by this paper
• The quantification of gene expression in an animal model of brain ischaemia using TaqMan real-time RT-PCR.

  2002cited by this paper
• Control of oxidative stress resistance by IP3 kinase in Drosophila melanogaster.

  2002cited by this paper
• Calcium dyshomeostasis and intracellular signalling in alzheimer's disease

  2002cited by this paper
• Imaging the progression of Alzheimer pathology through the brain

  2002cited by this paper
• Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling

  2002cited by this paper
• Gene Expression Profiles of Cholinergic Nucleus Basalis Neurons in Alzheimer's Disease

  2002cited by this paper
• Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

  2002cited by this paper
• Dysregulation of cellular calcium homeostasis in Alzheimer’s disease

  2001cited by this paper
• A Gene Expression Profile of Alzheimer's Disease

  2001cited by this paper
• The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.

  2001cited by this paper
• Empirical Bayes Analysis of a Microarray Experiment

  2001cited by this paper
• Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique.

  2001cited by this paper
• Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia

  2001cited by this paper
• Regulator of G protein signaling proteins: novel multifunctional drug targets.

  2001cited by this paper
• Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia

  2001cited by this paper
• Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray.

  2001cited by this paper
• High-resolution quantification of specific mRNA levels in human brain autopsies and biopsies.

  2000cited by this paper
• Expression profile of transcripts in Alzheimer's disease tangle‐bearing CA1 neurons

  2000cited by this paper
• Distribution of Active Glycogen Synthase Kinase 3β (GSK-3β) in Brains Staged for Alzheimer Disease Neurofibrillary Changes

  1999cited by this paper
• Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes.

  1999cited by this paper
• Attenuation of Gi- and Gq-mediated signaling by expression of RGS4 or GAIP in mammalian cells.

  1997cited by this paper
• The GTPase-activating Protein RGS4 Stabilizes the Transition State for Nucleotide Hydrolysis*

  1996cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• The inositol tris/tetrakisphosphate pathway—demonstration of Ins(l,4,5)P3 3-kinase activity in animal tissues

  1986cited by this paper

• Systematic review and meta‐analysis of bulk RNAseq studies in human Alzheimer's disease brain tissue

  2025cites this paper
• Capsaicin and TRPV1: A Novel Therapeutic Approach to Mitigate Vascular Aging

  2025cites this paper
• Novel differentially expressed genes and multiple biological pathways for Alzheimer's disease identified in brain tissue from African American donors

  2025cites this paper
• Cortical lipid metabolic pathway alteration of early Alzheimer’s disease and candidate drugs screen

  2024cites this paper
• Systematic review and meta-analysis of bulk RNAseq studies in human Alzheimer’s disease brain tissue

  2024cites this paper
• Rescue of synaptosomal glutamate release defects in tau transgenic mice by the tau aggregation inhibitor hydromethylthionine.

  2024cites this paper
• SGUQ: Staged Graph Convolution Neural Network for Alzheimer’s Disease Diagnosis using Multi-Omics Data

  2024cites this paper
• Tit wit: environmental and genetic drivers of cognitive variation along an urbanization gradient

  2024cites this paper
• Transcriptome-wide association study of Alzheimer disease reveals many differentially expressed genes and multiple biological pathways in brain tissue from African American donors

  2024cites this paper
• Acute exercise boosts NAD+ metabolism of human peripheral blood mononuclear cells.

  2024cites this paper
• Modelling Cross Talk in the Spatiotemporal System Dynamics of Calcium, IP3 and Nitric Oxide in Neuron Cells

  2024cites this paper
• Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond

  2023cites this paper
• Impact of TRPV1 on Pathogenesis and Therapy of Neurodegenerative Diseases

  2023cites this paper
• Increased Levels of the Parkinson’s Disease-Associated Gene ITPKB Correlate with Higher Expression Levels of α-Synuclein, Independent of Mutation Status

  2023cites this paper
• Identification of gene networks mediating regional resistance to tauopathy in late-onset Alzheimer’s disease

  2023cites this paper
• Fractional order interdependent nonlinear chaotic spatiotemporal calcium and Aβ dynamics in a neuron cell

  2023cites this paper
• Articulating target-mining techniques to disinter Alzheimer's specific targets for drug repurposing

  2022cites this paper
• Effect of disturbances in neuronal calcium and IP3 dynamics on β-amyloid production and degradation

  2022cites this paper
• Recent insights into viral infections as a trigger and accelerator in alzheimer's disease

  2022cites this paper
• Simulation of disturbances in interdependent calcium and β-amyloid dynamics in the nerve cell

  2022cites this paper
• Structural Scaffolds as Anti- Alzheimer Agents.

  2022cites this paper
• Transcriptional Regulation of the Synaptic Vesicle Protein Synaptogyrin-3 (SYNGR3) Gene: The Effects of NURR1 on Its Expression

  2022cites this paper
• CaMKIIβ knockdown decreases store-operated calcium entry in hippocampal dendritic spines

  2022cites this paper
• Impairment of Insulin Signalling Pathway Triggers a Series of Detrimental Effects in Alzheimer’s disease

  2021cites this paper
• Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer’s disease

  2021cites this paper
• Reassessment of Pioglitazone for Alzheimer’s Disease

  2021cites this paper
• Binding of Amyloid β(1–42)-Calmodulin Complexes to Plasma Membrane Lipid Rafts in Cerebellar Granule Neurons Alters Resting Cytosolic Calcium Homeostasis

  2021cites this paper
• Intracellular Calcium Dysregulation by the Alzheimer’s Disease-Linked Protein Presenilin 2

  2020cites this paper
• Identification of Dysregulated Genes for Late-Onset Alzheimer’s Disease Using Gene Expression Data in Brain

  2020cites this paper
• An Infectious Origin of Alzheimer’s Disease: An End for This Devastating Disorder?

  2020cites this paper
• The Role of Mitochondrial Calcium Homeostasis in Alzheimer’s and Related Diseases

  2020cites this paper
• Bioinformatic Analysis Reveals Phosphodiesterase 4D-Interacting Protein as a Key Frontal Cortex Dementia Switch Gene

  2020cites this paper
• Transcriptome Changes in the Alzheimer’s Disease Middle Temporal Gyrus: Importance of RNA Metabolism and Mitochondria-Associated Membrane Genes

  2019cites this paper
• Herpes simplex virus type 1 and Alzheimer’s disease: link and potential impact on treatment

  2019cites this paper
• Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.

  2019cites this paper
• Circulating Neurotoxic 5-HT2A Receptor Agonist Autoantibodies in Adult Type 2 Diabetes with Parkinson's Disease.

  2018cites this paper
• Reduced Cytosolic Calcium as an Early Decisive Cellular State in Parkinson’s Disease and Synucleinopathies

  2018cites this paper
• MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer’s Disease

  2018cites this paper
• Altered function of neuronal L-type calcium channels in ageing and neuroinflammation: Implications in age-related synaptic dysfunction and cognitive decline.

  2018cites this paper
• Circulating Neurotoxic 5-HT 2 A Receptor Agonist Autoantibodies in Adult Type 2 Diabetes with Parkinson ’ s Disease Page 3 of 11 Liposorber-LA-15 dextran sulfate cellulose chromatography

  2018cites this paper
• Cracking novel shared targets between epilepsy and Alzheimer’s disease: need of the hour

  2018cites this paper
• Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer’s Disease

  2018cites this paper
• Commentary: Alpha-Synuclein Aggregates Cause Calcium Dysregulation by Activating Calcium Pump SERCA

  2018cites this paper
• Cholinergic neuron gene expression differences captured by translational profiling in a mouse model of Alzheimer's disease.

  2017cites this paper
• Systematic identification of differential gene network to elucidate Alzheimer's disease

  2017cites this paper
• Hippocampal proteomics defines pathways associated with memory decline and resilience in normal aging and Alzheimer's disease mouse models

  2017cites this paper
• Computational investigation of Amyloid-β-induced location- and subunit-specific disturbances of NMDAR at hippocampal dendritic spine in Alzheimer’s disease

  2017cites this paper
• Interactions of Mitochondria/Metabolism and Calcium Regulation in Alzheimer’s Disease: A Calcinist Point of View

  2017cites this paper
• Single administration of a novel γ-secretase modulator ameliorates cognitive dysfunction in aged C57BL/6J mice.

  2016cites this paper
• Dissecting Complex and Multifactorial Nature of Alzheimer’s Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective

  2016cites this paper
• Gene Expression of Quaking in Sporadic Alzheimer’s Disease Patients is Both Upregulated and Related to Expression Levels of Genes Involved in Amyloid Plaque and Neurofibrillary Tangle Formation

  2016cites this paper
• Association of gene expression and methylation of UQCRC1 to the predisposition of Alzheimer's disease in a Chinese population.

  2016cites this paper
• Common variable immunodeficiency associated with microdeletion of chromosome 1q42.1-q42.3 and inositol 1,4,5-trisphosphate kinase B (ITPKB) deficiency

  2016cites this paper
• Explorative and targeted neuroproteomics in Alzheimer's disease.

  2015cites this paper
• Identifying Aβ-specific pathogenic mechanisms using a nematode model of Alzheimer's disease.

  2015cites this paper
• Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?*

  2015cites this paper
• Adenosine Receptors Differentially Regulate the Expression of Regulators of G-Protein Signalling (RGS) 2, 3 and 4 in Astrocyte-Like Cells

  2015cites this paper
• Proteomics Approach to Identify Biomarkers in Neurodegenerative Diseases.

  2015cites this paper
• Development of new tools to explore organelle calcium dynamics in vivo: a new fret-based calcium sensor and a mitochondria targeted channelrhodopsin

  2015cites this paper
• Ca2+ dysregulation in the endoplasmic reticulum related to Alzheimer's disease: A review on experimental progress and computational modeling

  2015cites this paper
• Rare Variants and Transcriptomics in Alzheimer disease

  2014cites this paper
• Calcium regulation of neural rhythms, memory and Alzheimer's disease

  2014cites this paper
• Deciphering Transcription and Methylation Specific to Late-Onset Alzheimer's Disease

  2014influential citation
• Inositol trisphosphate 3-kinase B is increased in human Alzheimer brain and exacerbates mouse Alzheimer pathology.

  2014cites this paper
• Macromolecular Crowding Induces Holo α-Lactalbumin Aggregation by Converting to Its Apo Form

  2014cites this paper
• Dysregulation of neuronal calcium signaling impairs axonal transport independent of tau in a model of Alzheimer's disease

  2014cites this paper
• Decision trees for the analysis of genes involved in Alzheimer's disease pathology.

  2014cites this paper
• The endoplasmic reticulum-mitochondria coupling: role of Presenilin-2

  2014cites this paper
• From synaptic spines to nuclear signaling: nuclear and synaptic actions of the amyloid precursor protein

  2013cites this paper
• S14G-humanin restored cellular homeostasis disturbed by amyloid-beta protein

  2013cites this paper
• Genes and pathways underlying regional and cell type changes in Alzheimer's disease

  2013cites this paper
• The Central Role of AMP-Kinase and Energy Homeostasis Impairment in Alzheimer’s Disease: A Multifactor Network Analysis

  2013cites this paper
• Association of CALHM1 gene polymorphism with late-onset Alzheimer disease

  2013cites this paper
• Cortical beta amyloid protein triggers an immune response, but no synaptic changes in the APPswe/PS1dE9 Alzheimer's disease mouse model.

  2013influential citation
• A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer's disease.

  2013influential citation
• The function of Drosophila IP3K2 in behavior and metabolism

  2013cites this paper
• Axonal and synaptic pathology in Alzheimer’s disease

  2013cites this paper
• Role of endoplasmic reticulum Ca2+ signaling in the pathogenesis of Alzheimer disease

  2013cites this paper
• Common Transcriptional Signatures in Brain Tissue from Patients with HIV-Associated Neurocognitive Disorders, Alzheimer’s Disease, and Multiple Sclerosis

  2012cites this paper
• Transcriptional Alterations Related to Neuropathology and Clinical Manifestation of Alzheimer’s Disease

  2012cites this paper
• Unveiling Clusters of RNA Transcript Pairs Associated with Markers of Alzheimer’s Disease Progression

  2012cites this paper
• Disturbed Ca2+ Homeostasis Increases Glutaminyl Cyclase Expression; Connecting Two Early Pathogenic Events in Alzheimer’s Disease In Vitro

  2012cites this paper
• Elevated ferric, calcium and magnesium ions in the brain induce protein aggregation in brain mitochondria.

  2012cites this paper
• Molecular changes in brain aging and Alzheimer's disease are mirrored in experimentally silenced cortical neuron networks.

  2012influential citation
• Amyloid-β Oligomers Induce Differential Gene Expression in Adult Human Brain Slices*

  2012cites this paper
• Gene expression profiling in human neurodegenerative disease

  2012cites this paper
• Down-Regulation of Energy Metabolism in Alzheimer's Disease is a Protective Response of Neurons to the Microenvironment

  2012cites this paper
• Oligomeric amyloid-β peptide affects the expression of genes involved in steroid and lipid metabolism in primary neurons.

  2012cites this paper
• Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brains.

  2012cites this paper
• Calcium channel blockers and Alzheimer's disease

  2012cites this paper
• Functional interactions between peroxisome proliferator-activated receptor-gamma and polipoprotein E isoforms in the regulation of neural functions in models of insulin resistance-relevance to Alzheimer's disease

  2012cites this paper
• Presenilins, Deranged Calcium Homeostasis, Synaptic Loss and Dysfunction in Alzheimer's Disease

  2012cites this paper
• Functional Genomics and Molecular Networks Gene Expression Regulations in Complex Diseases: Down Syndrome as a Case Study

  2012cites this paper
• Down syndrome with and without dementia: An in vivo proton Magnetic Resonance Spectroscopy study with implications for Alzheimer's disease

  2011cites this paper
• Road to Alzheimer’s Disease: The Pathomechanism Underlying

  2011cites this paper
• Short Communication Age-Related Changes in Gene Expression are Accelerated in Alzheimer's Disease

  2011cites this paper
• Deciphering the molecular signaling cascade in neuronal death

  2011cites this paper
• Gene expression reveals overlap between normal aging and Alzheimer's disease genes.

  2011cites this paper
• Age‐related changes in gene expression are accelerated in Alzheimer's disease

  2011cites this paper
• Down syndrome with and without dementia : and Alzheimer ’ s disease in the general population . An in vivo proton Magnetic Resonance Spectroscopy study

  2011cites this paper